Earlier this month at the World Economic Forum 2026 in Davos, Switzerland, Vasant Narasimhan, global CEO of Novartis, told CGTN that the Chinese mainland's biotech innovation now rivals that of the US 🧬.
According to Narasimhan, rapid development over recent decades, strong government support, and a booming talent pool have fueled this surge. The Chinese mainland has transformed into a hotbed for breakthroughs in gene therapy, vaccines, and sustainable biofuels 🌱.
What does this mean for young professionals, entrepreneurs, and students? New partnerships and funding channels are opening, from Shanghai's labs to Shenzhen's startups. For Latin American innovators eyeing Asia, the message is clear: it's time to build bridges and explore collaborative projects 🚀.
As biotech strides into the future, global cooperation will be key. Whether you're a student charting your research path or an investor scouting the next big discovery, the Chinese mainland-US biotech rivalry is shaping a more dynamic, balanced landscape 🌎.
Reference(s):
cgtn.com
